Around-the-clock: Caregiving at night for juveniles living with type 1 diabetes - a systematic review

Vivienne Howard1, Rebecca Maguire2, Enda De Bruin1

  • 1School of Psychology, Trinity College Dublin, Dublin, Ireland.

PubMed

Insights

Nocturnal caregiving for children with type 1 diabetes (T1D) is common and significantly impacts caregivers

Area of Science:

  • Pediatric Endocrinology
  • Caregiver Health
  • Health Services Research

Background:

  • Nocturnal caregiving for children with type 1 diabetes (T1D) is a demanding aspect of family caregiving.
  • The impact of this round-the-clock care on caregivers is often overlooked in clinical settings.

Purpose of the Study:

  • To systematically review and synthesize research on nocturnal caregiving practices (NCP) for children with T1D.
  • To explore the prevalence, nature, and impacts of NCP on caregivers.
  • To evaluate technology's role in supporting NCP and identify solutions for burden mitigation.

Main Methods:

  • Systematic review of peer-reviewed studies published since 1997, identified through searches of six major databases.
  • Inclusion of quantitative, qualitative, and mixed-methods studies addressing NCP for juveniles with T1D.
  • Risk of bias analysis and synthesis of quantitative data; thematic analysis of qualitative data.

Main Results:

  • 31 studies involving 3,547 caregivers were included; 88% engaged in NCP.
  • Over 50% of caregivers experienced inadequate sleep, and 54% reported poor sleep quality.
  • Adverse impacts included exhaustion, decision-making difficulties, and negative effects on mood and physical health; technology benefits were equivocal.

Conclusions:

  • Nocturnal caregiving for children with T1D is pervasive and significantly affects caregiver well-being.
  • Current clinical practice rarely addresses the sleep needs of these caregivers.
  • Recommendations include modifying care guidelines and developing psychosocial supports to acknowledge and mitigate the burden of NCP.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
137
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842